📱 حمّل تطبيق خبر الآن! App Store Khabr Live
🕐 --:--
-- --
عاجل
⚡ عاجل: كريستيانو رونالدو يُتوّج كأفضل لاعب كرة قدم في العالم ⚡ أخبار عاجلة تتابعونها لحظة بلحظة على خبر ⚡ تابعوا آخر المستجدات والأحداث من حول العالم
⌘K
AI مباشر | -- مشاهد مباشر
1,087,933 مقال 408 مصدر نشط 228 قناة مباشرة 4,191 خبر اليوم
آخر تحديث: منذ ثانية

A new flu vaccine geared to older people is coming soon

صحة
NPR
2026/08/06 - 17:06 506 مشاهدة
تحليل ذكي | AI Editorial Analysis

Health A new flu vaccine geared to older people is coming soon August 6, 20261:06 PM ET Rob Stein A new kind of flu vaccine made with mRNA technology will soon be available.

Marco Bello/Bloomberg/Getty Images hide caption toggle caption Marco Bello/Bloomberg/Getty Images For the latest stories on the science of healthy living, subscribe to NPR's Health newsletter.

The Food and Drug Administration approved Moderna's mRNA-based vaccine against seasonal influenza for people 50 and older, the company said late Wednesday.

هذا الخبر من NPR. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.

Health A new flu vaccine geared to older people is coming soon August 6, 20261:06 PM ET Rob Stein A new kind of flu vaccine made with mRNA technology will soon be available. Marco Bello/Bloomberg/Getty Images hide caption toggle caption Marco Bello/Bloomberg/Getty Images For the latest stories on the science of healthy living, subscribe to NPR's Health newsletter.  The Food and Drug Administration approved Moderna's mRNA-based vaccine against seasonal influenza for people 50 and older, the company said late Wednesday. It's the first approved vaccine for flu that uses the same technology as COVID-19 shots. Health FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned The vaccine is called mFLUSIVA, and Moderna says it will be available "in a few weeks" — in time for the 2026-2027 respiratory virus season in the U.S. "The FDA approval of mFLUSIVA … demonstrates the continued strength and versatility of our mRNA platform," said Stéphane Bancel, Moderna's chief executive officer, in a statement. "Flu remains a significant public health challenge, and mFLUSIVA provides an important new option for America's seniors. This approval also reflects the ongoing potential of our mRNA platform to help address important public health challenges through continued scientific innovation." Sponsor Message Company research involving more than 40,000 people found that mFLUSIVA is safe and appears to produce stronger protection than traditional flu vaccines. The FDA's decision was being closely monitored because of the Trump administration's hostility toward mRNA technology. President Trump embraced mRNA technology during his first term to produce the COVID vaccines, an achievement widely praised as a medical triumph that saved millions of lives. But the backlash against pandemic responses, including vaccine mandates, led to the vaccines and mRNA technology being vilified by some and becoming the focus of widespread misinformation. Secretary of Health and Human Serv...
المصدر: NPR | Source: NPR

ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة NPR. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.

This article was originally published by NPR. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.

مشاركة:

المزيد عن صحة | More on Health

هذا الخبر ضمن تغطية خبر لقسم صحة. نقدّم لك تحليلات ذكية وملخصات يومية لأهم الأخبار من مصادر موثوقة متعددة. المصدر: NPR. يوجد 6 مقالات مرتبطة بهذا الموضوع.

This article is part of Khabr's coverage of Health. We provide AI-powered analysis, summaries, and multi-source aggregation to keep you informed. Source: NPR. Tags: flu vaccine, older people, healthcare.

مقالات ذات صلة

خبر — منصة إخبارية ذكية | Khabr — AI-Powered News Platform

خبر هو أول مجمّع أخبار عربي يعمل بالذكاء الاصطناعي. نقدم تحليلات ذكية وملخصات تلقائية ورواية صوتية لكل خبر من أكثر من 700 مصدر موثوق. نضيف قيمة تحريرية فريدة من خلال أدوات الذكاء الاصطناعي التي تساعدك على فهم الأخبار بعمق أكبر.

Khabr is the first AI-powered Arabic news aggregator. We provide AI-generated editorial analysis, automated summaries, audio narration, and fact-checking for every article from 700+ trusted sources. Our platform adds unique editorial value through AI tools that help you understand the news more deeply.

AI
يا هلا! اسألني أي شي 🎤
🔍
FREE Free 1GB Internet + Free International Calls

$1 trial — eSIM in 190+ countries — No roaming charges

Download Free